22 Jun. 2026

Postdoc – Vision to Action Lab

Research
Application Starts: 22 Jun. 2026

A Call for one Research fellowship (Bolsas de Pós-Doutoramento) for postdoc is open at Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud (Champalimaud Foundation) in the context of the project entitled “How working memory guides decisions in zebrafish larvae”, with reference “2023.15924.PEX” from the call No “PEX2023”, funded by the Fundação para a Ciência e Tecnologia.

Charge switching lipid nanoparticles deliver nucleic acids without triggering inflammation

Host

Miguel Seabra, PhD, Ocular Low-cost Gene Therapy


Venue

Seminar Room

17 June 2026

[ day hospital ]

The Day Hospital is a place where treatment meets compassion. 

Here, patients receive systemic treatments, namely chemotherapy, in an environment designed to promote comfort, privacy and reassurance.

Individual treatment booths allow family members to be present, creating moments of support throughout the care journey.

Nurses and doctors remain close at every step, carefully monitoring treatments, responding to patients’ needs and ensuring personalised and attentive care.

16 Jun. 2026

PhD Student Position - Learning Lab

Research
Application Starts: 16 Jun. 2026

As part of a Marie-Curie Doctoral Network (ELEVATE), we are offering a PhD student position. The proposed project sits at the interface of computational neuroscience and neuromorphic engineering, and is embedded within a strong network of European academic and industrial partners.

Decoding the response to cell death

Host

Inês Ramos, PhD, Tissue Immunity Lab


Venue

Seminar Room

The neural basis of hunting behaviour

Host

Michael Orger, PhD, Vision to Action Lab


Venue

Seminar Room

11 June 2026

[ principal investigator’s office ]

The Principal Investigator’s Office is a space where ideas are challenged, discoveries take shape and research moves forward.

Here, researchers get together to discuss projects, share findings and debate scientific publications. It is a space for mentoring, project management and learning – where emerging questions spark new possibilities.

Through dialogue, critical thinking and collaboration, individual efforts become collective progress.

01 June 2026

Early-stage breast cancer: more effective and less toxic post-operative therapy with low-dose Tamoxifen

A study just published in the prestigious Journal of Clinical Oncology definitively establishes the introduction of low-dose Tamoxifen into clinical practice as post-surgical therapy for the prevention of ductal carcinoma in situ (DCIS), the initial non-invasive form that accounts for around 25% of all breast cancers diagnosed through mammographic screening.

Subscribe to Champalimaud Research
Loading
Please wait...